Please Wait
Applying Filters...
menu
    • menu
    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-24

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-17

    Virtual Booth

    Contact Supplier

    Menu

    Frovatriptan

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 29,688Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Allegro's osteoarthritis treatment shows safe results in studies
    Allegro's osteoarthritis treatment shows safe results in studies

    25 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/25/3048441/0/en/Allegro-s-injectable-osteoarthritis-treatment-generates-positive-safety-results-in-preclinical-studies.html

    GLOBENEWSWIRE
    25 Mar 2025
    Share Share
    Allegro’s OA Gel Demonstrates Preclinical Safety in Injectable Form
    Allegro’s OA Gel Demonstrates Preclinical Safety in Injectable Form

    11 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/11/2995076/0/en/Allegro-s-osteoarthritis-injectable-shock-absorbing-gel-demonstrates-preclinical-safety.html

    GLOBENEWSWIRE
    11 Dec 2024
    Share Share
    Pfizer announces positive results from phase 2b/3 ALLEGRO trial of ritlecitinib
    Pfizer announces positive results from phase 2b/3 ALLEGRO trial of ritlecitinib

    06 Aug 2021

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=140611&sid=2

    PHARMABIZ
    06 Aug 2021
    Share Share
    Bausch inks $50M option to grab Allegro's eye disease pipeline
    Bausch inks $50M option to grab Allegro's eye disease pipeline

    22 Sep 2020

    // A. Al Idrus FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/bausch-inks-50m-option-to-grab-allegro-s-eye-disease-pipeline

    A. Al Idrus FIERCE BIOTECH
    22 Sep 2020
    Share Share
    Detailed Study on the Global Frovatriptan Market
    Detailed Study on the Global Frovatriptan Market

    28 May 2020

    // NEWSDISTINCT

    https://www.newsdistinct.com/potential-impact-of-coronavirus-outbreak-on-frovatriptan-market-by-product-analysis-2019-2026/

    NEWSDISTINCT
    28 May 2020
    Share Share
    Frovatriptan Market Overview Industry Demand, Devp & Growth Forecast Report 2026
    Frovatriptan Market Overview Industry Demand, Devp & Growth Forecast Report 2026

    07 May 2020

    // 3WNEWS

    https://3wnews.org/industry/739647/frovatriptan-market-overview-industry-demand-development-and-growth-forecast-report-2026/

    3WNEWS
    07 May 2020
    Share Share